Merontos, Angelic H.
HRN: 22-47-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/17/2023
01/23/2023
IV
4.5g
Q8H
Pelvic Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes